SYK (Stryker) ROCE % : 12.70% (As of Sep. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Stryker ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Stryker's annualized ROCE % for the quarter that ended in Sep. 2024 was 12.70%.

Stryker ROCE % Historical Data

The historical data trend for Stryker's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker ROCE % Chart

Stryker Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

12.06

8.14

9.05

10.03

12.48

Stryker Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															12.13	16.30	12.07	13.01	12.70

Stryker ROCE % Calculation

Stryker's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	3906	/	( ( (36884 - 6303)	+	(39912 - 7921) )	/ 2 )
	=	3906	/	( (30581	+	31991)	/ 2 )
	=	3906	/	31286
	=	12.48 %

Stryker's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	4340	/	( ( (39130 - 6926)	+	(43833 - 7669) )	/ 2 )
	=	4340	/	( ( 32204	+	36164 )	/ 2 )
	=	4340	/	34184
	=	12.70 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Stryker (NYSE:SYK) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Stryker ROCE % Related Terms

Thank you for viewing the detailed overview of Stryker's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Stryker Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (NYSE:SYK) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

SYK:Mexico 1SYK:Italy 0R2S:UK SYK:Germany SYK:Germany S1YK34:Brazil SYK:Austria

Address

1941 Stryker Way, Portage, MI, USA, 49002

Website

https://www.stryker.com

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.

Executives

Spencer S Stiles	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Kevin Lobo	officer: Group Pres., Neurotech & Spine	STRYKER, 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Ronda E Stryker	director	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
M Kathryn Fink	officer: VP, Global Human Resources	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Viju Menon	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Glenn S Boehnlein	officer: Vice President, CFO	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Robert S Fletcher	officer: VP, Chief Legal Officer	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Berry William E Jr	officer: Vice President, Controller	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Allan C. Golston	director	2825 AIRVIEW BLVD., KALAMAZOO MI 49002
Srikant Datar	director	ICF INTERNATIONAL, INC., 9300 LEE HIGHWAY, FAIRFAX VA 22031
James Andrew Pierce	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Giovanni Caforio	director	BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Timothy J Scannell	officer: Group President	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Roch Doliveux	director	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Katherine Ann Owen	officer: VP	2825 AIRVIEW BLVD., KALAMAZOO MI 49002